TABLE 2.

Incidence of Components of MS

VariablesNo./Total (%)
LGA/GDMAGA/GDMLGA/ControlAGA/Control
Obesity (BMI >85th percentile)
    Age 6 y13/39 (33)7/49 (14)11/41 (27)9/41 (22)
    Age 7 y14/35 (40)3/49 (6)10/41 (24)10/37 (27)
    Age 9 y10/23 (44)9/34 (26)7/25 (28)7/25 (28)
    Age 11 y7/20 (35)9/38 (24)8/26 (31)6/25 (24)
BP >90th percentile*
    Age 6 y7/34 (21)15/47 (31)4/40 (10)8/40 (20)
    Age 7 y15/33 (45)14/48 (29)7/41 (17)8/36 (22)
    Age 9 y7/22 (32)5/34 (15)5/25 (20)3/24 (13)
    Age 11 y4/19 (21)5/38 (24)3/26 (12)2/24 (8)
HDL level <5th percentile
    Age 6 y7/17 (41)7/23 (30)13/26 (50)6/19 (32)
    Age 7 y12/25 (48)3/33 (9)8/25 (32)10/25 (40)
    Age 9 y4/19 (21)3/28 (11)2/20 (10)3/20 (15)
    Age 11 y4/10 (40)4/21 (19)4/18 (22)3/11 (27)
Triglyceride level >95th percentile
    Age 9 y3/19 (16)6/29 (21)1/20 (5)3/20 (15)
    Age 11 y3/14 (21)2/30 (7)1/24 (5)2/19 (11)
Abnormal glucose level
    Age 6 y0/25 (0)0/34 (0)1/28 (4)0/25 (0)
    Age 7 y1/27 (4)0/35 (0)1/27 (4)0/26 (0)
    Age 9 y0/20 (0)0/30 (0)0/22 (0)1/21 (5)
    Age 11 y0/15 (0)2/31 (6)4/24 (17)1/21 (5)
Glucose/insulin ratio, mean (SD)
    Age 9 y8.27 (4.48)8.65 (4.19)6.98 (2.39)8.25 (3.98)
    Age 11 y7.53 (4.44)8.13 (3.30)8.40 (3.13)8.24 (4.86)
Homeostasis model, mean (SD)
    Age 9 y2.1 (1.8)2.0 (2.6)1.8 (1.5)1.7 (1.3)
    Age 11 y3.6 (2.2)3.3 (2.4)3.1 (2.2)3.4 (2.7)
  • * Elevated systolic or diastolic BP.

  • Postprandial glucose level >140 mg/dL at age 6 or 7 or fasting glucose level >110 mg/dL at age 7 or 9 years. No group differences were identified.